Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.34 |
| ▸ | ESRRB | O95718 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11611500 | 0.93 | BLM (0.52) | CA1CA2SMN1; SMN2ZDHHC7BLM | |
| SCHEMBL994205 | 0.93 | BLM (0.52) | CA1CA2SMN1; SMN2ZDHHC7BLM | |
| SCHEMBL11600011 | 0.93 | BLM (0.52) | CA1CA2SMN1; SMN2ZDHHC7BLM | |
| SCHEMBL7105090 | 0.89 | SMN1; SMN2 (0.46) | CA1CA2SMN1; SMN2ZDHHC7CA14 | |
| SCHEMBL15779692 | 0.89 | CA1 (0.42) | CA1CA2SMN1; SMN2ZDHHC7BLM | |
| SCHEMBL2779851 | 0.88 | CA1 (0.61) | CA1CA2ZDHHC7TSHRABCB1 | |
| SCHEMBL7947656 | 0.88 | CA1 (0.61) | CA1CA2ZDHHC7TSHRABCB1 | |
| SCHEMBL11298047 | 0.88 | CA1 (0.61) | CA1CA2ZDHHC7TSHRABCB1 | |
| SCHEMBL11602158 | 0.87 | BLM (0.62) | CA1CA2SMN1; SMN2ZDHHC7BLM | |
| SCHEMBL9808025 | 0.87 | CA1 (0.46) | CA1CA2SMN1; SMN2ZDHHC7BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751880-B2 | Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and imide compound | CANON KABUSHIKI KAISHA (JP) | 2017-09-05 | — | — | US | disclosed |
| US-9751880-B2 | Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and imide compound | CANON KABUSHIKI KAISHA (JP) | 2017-09-05 | — | — | US | disclosed |
| US-20160115163-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, ELECTROPHOTOGRAPHIC APPARATUS, AND IMIDE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20120282386-A1 | LANTHIONINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115163-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, ELECTROPHOTOGRAPHIC APPARATUS, AND IMIDE COMPOUND | PPIE, PPIG, PPIA | CA1 3064/4885CA2 2676/4885SMN1; SMN2 4207/4885 |
| US-20120282386-A1 | LANTHIONINE DERIVATIVES | CASR, KCNJ5, CALCR | CA1 522/4885CA2 92/4885SMN1; SMN2 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.